Allergan completes acquisition of Optical Micro Systems.IRVINE, Calif.--(BUSINESS WIRE)--Jan. 27, 1995--Allergan Inc. (NYSE NYSE See: New York Stock Exchange :AGN) announced that its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , Allergan Medical Optics Inc., has completed its acquisition of Optical Micro Systems (OMS OMS - Opportunity Management System ). OMS, based in North Andover, Mass., develops and manufactures phacoemulsification phacoemulsification /phaco·emul·si·fi·ca·tion/ (-e-mul?si-fi-ka´shun) a method of cataract extraction in which the lens is fragmented by ultrasonic vibrations and simultaneously irrigated and aspirated. equipment, which is used during cataract surgery. The company achieved $8.6 million in worldwide sales in 1994. "Allergan and OMS customers will benefit from this transaction because of the additional product and service choices it offers them," said William C. Shepherd, Allergan president and chief executive officer. "We look forward to working with the employees of OMS. Together, we will develop a steady flow of advanced phaco equipment and new technologies for our ophthalmic surgical customers." The strategic acquisition of Ioptex Research last December and the addition of the OMS line of phaco equipment strengthen Allergan's global marketing position in the ophthalmic surgical market. Approximately 3 million cataract surgeries per year worldwide remove the patient's natural clouded lens and replace it with an intraocular lens or IOL IOL Intraocular lens, see there . Phacoemulsification utilizes a small incision to emulsify e·mul·si·fy v. To make into an emulsion. e·mul  si·fi·ca tion n. and extract the patient's natural clouded lens. Allergan, the world leader in small incision IOLs, recently introduced the AMO(R) Foldable PhacoFlex(R) II SI-30NB(TM), the number one selling IOL. This lens is thinner than other silicone IOLs, allowing insertion through a very small incision. Allergan Inc., a global health care company with headquarters in Irvine, Calif., develops, manufactures, and markets specialty therapeutic products for eye and skin care and neuromuscular disorders. A technology-driven company, Allergan is working to be the partner of choice for ever better health care. CONTACT: Allergan, Irvine Jeff D'Eliscu, 714/752-4636 (work) 714/675-9475 (home) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion